Recordati Rare Diseases
Alex Alexandrakis is an experienced General Manager currently serving as the Country Head for Greece, Cyprus, and Malta at Recordati Rare Diseases EMEA since September 2022, overseeing commercial, marketing, and medical functions in oncology, endocrinology, and metabolics. Previously, Alex held various roles at EUSA Pharma, including Regional Business Director for South Europe and Scientific & Market Access Manager for Central & Eastern Europe and CIS, where responsibilities included promoting oncology and rare disease portfolios and managing stakeholder relationships for market access. Other notable positions include International Development Director at TheOTCLab, Business Unit Director at Gerolymatos International, and leadership roles at Apivita SA and Korres Natural Products S.A., cumulatively demonstrating extensive experience in international business development and market strategy across diverse sectors. Alex holds a BA in Economic Geography from The London School of Economics and an MSc in Economic Development and Environment from King's College London.
This person is not in any offices
Recordati Rare Diseases
3 followers
Recordati Rare Diseases is a pharmaceutical company that provides treatment for patients with rare diseases. Created in 1990, Recordati Rare Diseases is one of the most active companies in the field of rare diseases.